ABCA1 mRNA and Protein Distribution Patterns Predict Multiple Different Roles and Levels of Regulation

Abe-Dohmae, 2000, Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line, Biochemistry, 39, 11092, 10.1021/bi0008175 Anderson, 1996, Direct interactions of Coxsackivirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis, J Virol, 70, 4632, 10.1128/jvi.70.7.4632-4645.1996 Bodzioch, 1999, The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier Disease, Nat Genet, 22, 347, 10.1038/11914 Bortnick, 2000, The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines, J Biol Chem, 275, 28634, 10.1074/jbc.M003407200 Broccardo, 1999, The ABCA subclass of mammalian transporters, Biochim Biophys Acta, 1461, 395, 10.1016/S0005-2736(99)00170-4 Brooks-Wilson, 1999, Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency, Nat Genet, 22, 336, 10.1038/11905 Cavelier, 2001, Regulation and activity of the human ABCA1 gene in transgenic mice, J Biol Chem, 276, 18046, 10.1074/jbc.M100565200 Christiansen-Weber, 2000, Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency, Am J Pathol, 157, 1017, 10.1016/S0002-9440(10)64614-7 Costet, 2000, Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor, J Biol Chem, 275, 28240, 10.1074/jbc.M003337200 Danik, 1999, Brain lipoprotein metabolism and its relation to neurodegenerative disease, Crit Rev Neurobiol, 13, 357, 10.1615/CritRevNeurobiol.v13.i4.20 Demetriou, 1998, The pregnant patient with partial lipodystrophy developing acute renal failure – onset of de novo membranoproliferative glomerulonephritis, Nephrol Dial Transplant, 13, 2121, 10.1093/ndt/13.8.2121 Gygi, 1999, Correlation between protein and mRNA abundance in yeast, Mol Cell Biochem, 19, 1720, 10.1128/MCB.19.3.1720 Hedrick, 2000, Short-term feeding of an atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism, Arterioscler Thromb Vasc Biol, 20, 1946, 10.1161/01.ATV.20.8.1946 Kaminski, 2000, Identification of a novel human sterol-sensitive ATP-binding cassette transporter (ABCA7), Biochem Biophys Res Commun, 273, 532, 10.1006/bbrc.2000.2954 Klein, 1999, An inventory of the human ABC proteins, Biochim Biophys Acta, 1461, 237, 10.1016/S0005-2736(99)00161-3 Komminoth, 1996, Detection of mRNA in tissue sections using DIG-labeled RNA and oligonucleotide probes, Nonradioactive in situ hybridization manual, 126 Ladu, 2000, Lipoproteins in the central nervous system, Ann NY Acad Sci, 903, 167, 10.1111/j.1749-6632.2000.tb06365.x Langmann, 1999, Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages, Biochem Biophys Res Commun, 257, 29, 10.1006/bbrc.1999.0406 Lawn, 2001, Localization of human ATP-Binding cassette transporter 1 (ABC1) in normal and atherosclerotic tissues, Arterioscler Thromb Vasc Biol, 21, 378, 10.1161/01.ATV.21.3.378 Levy, 1998, Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon, Immunol Res, 18, 55, 10.1007/BF02786513 Marcil, 1999, Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux, Lancet, 354, 1341, 10.1016/S0140-6736(99)07026-9 McNeish, 2000, High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1, Proc Natl Acad Sci, 97, 4245, 10.1073/pnas.97.8.4245 Oram, 2000, ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages, J Biol Chem, 275, 34508, 10.1074/jbc.M006738200 Oram, 2000, ABCA1-mediated transport of cellular cholesterol and phosopholipids to HDL apoplipoproteins, Curr Opin Lipidol, 11, 253, 10.1097/00041433-200006000-00005 Pollock, 1986, Membranoproliferative glomerulonephritis, type II and partial lipodystrophy in an adult, Am J Kidney Dis, 8, 274, 10.1016/S0272-6386(86)80041-5 Power, 1990, Familial incidence of C3 nephritic factor, partial lipodystrophy and membranoproliferative glomerulonephritis, Q J Med, 75, 387 Pullinger, 2000, Analysis of hABC1 Gene 5′ End: Additional peptide sequence, promoter region, and four polymorphisms, Biochem Biophys Res Commun, 271, 451, 10.1006/bbrc.2000.2652 Remaley, 2001, Apoplipoprotein specificity for lipid efflux by the human ABCA1 transporter, Biochem Biophys Res Commun, 280, 818, 10.1006/bbrc.2000.4219 Repa, 2000, Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers, Science, 289, 1524, 10.1126/science.289.5484.1524 Rust, 1999, Tangier Disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1, Nat Genet, 22, 352, 10.1038/11921 Schmitz, 2000, ABC transporters in cellular lipid trafficking, Curr Opin Lipidol, 11, 493, 10.1097/00041433-200010000-00007 Schwartz, 2000, ABC1 gene expression and ApoA-1-mediated cholesterol efflux are regulated by LXR, Biochem Biophys Res Commun, 274, 794, 10.1006/bbrc.2000.3243 Singaraja, 2001, Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1, J Biol Chem, 276, 33969, 10.1074/jbc.M102503200 Song, 2000, Glomerulosclerosis in adriamycin-induced nephrosis is accelerated by a lipid-rich diet, Pediatr Nephrol, 15, 196, 10.1007/s004670000464 Vrtovsnik, 1992, Sphingomyelin and cholesterol modulate sodium coupled uptake in proximal tubular cells, Kidney Int, 41, 983, 10.1038/ki.1992.150 Zager, 2000, Plasma membrane cholesterol: A critical determinant of cellular energetics and tubular resistance to attack, Kidney Int, 58, 193, 10.1046/j.1523-1755.2000.00154.x Zager, 1999, Increased proximal tubular cholesterol content: Implications for cell injury and “acquired cytoresistance.”, Kidney Int, 56, 1788, 10.1046/j.1523-1755.1999.00745.x